In this episode of the RevGenetics Podcast, Les and Amy explore a groundbreaking breakthrough in diabetes research that targets cellular destruction right at the source. In type 2 diabetes, the misfolding of the amylin hormone under stress creates sticky clumps that destroy critical pancreatic cells. Scientists are now proposing an innovative solution: a custom molecular "bodyguard" designed to block misfolded proteins from clumping together and safeguard your body's natural insulin factories. Could protecting these microscopic battlegrounds revolutionize how we treat diabetes and cellular damage? Join us as we unpack the implications of this study and what it means for the future of metabolic health and cellular longevity.
Podden och tillhörande omslagsbild på den här sidan tillhör
RevGenetics. Innehållet i podden är skapat av RevGenetics och inte av,
eller tillsammans med, Poddtoppen.
